ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Abstract 2894: XMT-1592, a site-specific Dolasynthen-based NaPi2b-targeted antibody-drug conjugate for the treatment of ovarian cancer and lung adenocarcinoma
Mapping Intimacies
◽
10.1158/1538-7445.am2020-2894
◽
2020
◽
Author(s):
Shawn Fessler
◽
Anouk Dirksen
◽
Scott D. Collins
◽
Ling Xu
◽
Winnie Lee
◽
...
Keyword(s):
Ovarian Cancer
◽
Lung Adenocarcinoma
◽
Antibody Drug Conjugate
◽
Site Specific
◽
Drug Conjugate
◽
A Site
◽
Antibody Drug
Download Full-text
Related Documents
Cited By
References
Abstract 3897: Stability and safety evaluation of STRO-002, a site-specific anti-folate receptor alpha antibody-drug conjugate for the potential treatment of ovarian and endometrial cancers
10.1158/1538-7445.sabcs18-3897
◽
2019
◽
Author(s):
Willy Solis
◽
Venita De Almeida
◽
Cristina Abrahams
◽
Xiaofan Li
◽
Tyler Heibeck
◽
...
Keyword(s):
Folate Receptor
◽
Safety Evaluation
◽
Potential Treatment
◽
Antibody Drug Conjugate
◽
Site Specific
◽
Receptor Alpha
◽
Drug Conjugate
◽
Endometrial Cancers
◽
A Site
◽
Antibody Drug
Download Full-text
ARX788, a Site-specific Anti-HER2 Antibody–Drug Conjugate, Demonstrates Potent and Selective Activity in HER2-low and T-DM1–resistant Breast and Gastric Cancers
Molecular Cancer Therapeutics
◽
10.1158/1535-7163.mct-19-1004
◽
2020
◽
Vol 19
(9)
◽
pp. 1833-1843
◽
Cited By ~ 4
Author(s):
Lillian Skidmore
◽
Sukumar Sakamuri
◽
Nick A. Knudsen
◽
Amha Gebre Hewet
◽
Snezana Milutinovic
◽
...
Keyword(s):
Antibody Drug Conjugate
◽
Site Specific
◽
Gastric Cancers
◽
Drug Conjugate
◽
A Site
◽
Antibody Drug
◽
Selective Activity
Download Full-text
A Case Study to Identify the Drug Conjugation Site of a Site-Specific Antibody-Drug-Conjugate Using Middle-Down Mass Spectrometry
Journal of the American Society for Mass Spectrometry
◽
10.1007/s13361-019-02296-2
◽
2019
◽
Vol 30
(11)
◽
pp. 2419-2429
◽
Cited By ~ 7
Author(s):
Oscar Hernandez-Alba
◽
Stéphane Houel
◽
Steve Hessmann
◽
Stéphane Erb
◽
David Rabuka
◽
...
Keyword(s):
Mass Spectrometry
◽
Specific Antibody
◽
Antibody Drug Conjugate
◽
Site Specific
◽
Drug Conjugate
◽
Drug Conjugation
◽
A Site
◽
Antibody Drug
Download Full-text
Targeted Delivery of LXR Agonist Using a Site-Specific Antibody–Drug Conjugate
Bioconjugate Chemistry
◽
10.1021/acs.bioconjchem.5b00203
◽
2015
◽
Vol 26
(11)
◽
pp. 2216-2222
◽
Cited By ~ 28
Author(s):
Reyna K. V. Lim
◽
Shan Yu
◽
Bo Cheng
◽
Sijia Li
◽
Nam-Jung Kim
◽
...
Keyword(s):
Specific Antibody
◽
Targeted Delivery
◽
Antibody Drug Conjugate
◽
Site Specific
◽
Drug Conjugate
◽
A Site
◽
Antibody Drug
Download Full-text
Abstract 742: Nonclinical safety evaluation of STRO-001, a site-specific anti-CD74 antibody-drug conjugate for the potential treatment of B-cell malignancies
10.1158/1538-7445.am2018-742
◽
2018
◽
Author(s):
Willy Solis
◽
Venita De Almeida
◽
Abigail Yu
◽
Maureen Bruhns
◽
James Zawada
◽
...
Keyword(s):
B Cell
◽
Safety Evaluation
◽
Potential Treatment
◽
Antibody Drug Conjugate
◽
B Cell Malignancies
◽
Site Specific
◽
Drug Conjugate
◽
A Site
◽
Antibody Drug
Download Full-text
RN927C, a Site-Specific Trop-2 Antibody–Drug Conjugate (ADC) with Enhanced Stability, Is Highly Efficacious in Preclinical Solid Tumor Models
Molecular Cancer Therapeutics
◽
10.1158/1535-7163.mct-16-0431
◽
2016
◽
Vol 15
(11)
◽
pp. 2698-2708
◽
Cited By ~ 34
Author(s):
Pavel Strop
◽
Thomas-Toan Tran
◽
Magdalena Dorywalska
◽
Kathy Delaria
◽
Russell Dushin
◽
...
Keyword(s):
Solid Tumor
◽
Tumor Models
◽
Antibody Drug Conjugate
◽
Site Specific
◽
Drug Conjugate
◽
A Site
◽
Enhanced Stability
◽
Antibody Drug
Download Full-text
A Novel Immunocapture, LC-MS/MS Assay for Total Conjugated Drug in Support of a Site-Specific Antibody Drug Conjugate (ADC)
10.26226/morressier.57ea3d69d462b8028d88e4f9
◽
2016
◽
Author(s):
Brian Melo
Keyword(s):
Specific Antibody
◽
Antibody Drug Conjugate
◽
Site Specific
◽
Drug Conjugate
◽
A Site
◽
Antibody Drug
Download Full-text
PF-06804103, A Site-specific Anti-HER2 Antibody–Drug Conjugate for the Treatment of HER2-expressing Breast, Gastric, and Lung Cancers
Molecular Cancer Therapeutics
◽
10.1158/1535-7163.mct-20-0237
◽
2020
◽
Vol 19
(10)
◽
pp. 2068-2078
◽
Cited By ~ 2
Author(s):
Edmund I. Graziani
◽
Matthew Sung
◽
Dangshe Ma
◽
Bitha Narayanan
◽
Kimberly Marquette
◽
...
Keyword(s):
Antibody Drug Conjugate
◽
Site Specific
◽
Lung Cancers
◽
Drug Conjugate
◽
A Site
◽
Antibody Drug
Download Full-text
Abstract 2965:In vitroandin vivoactivity of a site-specific SeriMab antibody-drug conjugate (ADC) using an indolino-benzodiazepine DNA-alkylating agent
10.1158/1538-7445.am2016-2965
◽
2016
◽
Author(s):
Dilrukshi Vitharana
◽
Alan Wilhelm
◽
Luke Harris
◽
Katie Archer
◽
Manami Shizuka
◽
...
Keyword(s):
Alkylating Agent
◽
Antibody Drug Conjugate
◽
Site Specific
◽
Drug Conjugate
◽
A Site
◽
Antibody Drug
◽
Dna Alkylating Agent
Download Full-text
Abstract 3897: Stability and safety evaluation of STRO-002, a site-specific anti-folate receptor alpha antibody-drug conjugate for the potential treatment of ovarian and endometrial cancers
10.1158/1538-7445.am2019-3897
◽
2019
◽
Author(s):
Willy Solis
◽
Venita De Almeida
◽
Cristina Abrahams
◽
Xiaofan Li
◽
Tyler Heibeck
◽
...
Keyword(s):
Folate Receptor
◽
Safety Evaluation
◽
Potential Treatment
◽
Antibody Drug Conjugate
◽
Site Specific
◽
Receptor Alpha
◽
Drug Conjugate
◽
Endometrial Cancers
◽
A Site
◽
Antibody Drug
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close